Passive Smoking Increases Exposure to Polycyclic Aromatic Hydrocarbons and Leads to Prolonged Lipid Oxidation: Lessons from a Natural Experiment in Travelers from Los Angeles to Beijing

Yan Lin,Yifang Zhu,Xinghua Qiu,Fen Yin,Chi-Hong Tseng,Jesus A Araujo
DOI: https://doi.org/10.21203/rs.3.rs-68389/v1
2020-01-01
Abstract:Background: There are drastic differences in smoking prevalence and control policies among different countries. However, the impact of international travels on passive smoking exposures and subsequent health effects remained unknown. Methods: We recruited 27 non-smokers who travelled from Los Angeles to Beijing for 10 weeks in 2014 and 2015. Urine samples (n=197) were collected before (LA-before), during (Beijing), and after (LA-after) the trip, for the assessment of biomarkers of passive smoking (cotinine), PAHs exposure (hydroxylated-PAHs), and lipid peroxidation (malondialdehyde and 8-isoprostane). Results: The geometric mean concentrations of urinary cotinine were 0.13, 1.50, and 0.22 µg/g creatinine in LA-before, Beijing, and LA-after, respectively. Likewise, hydroxylated-PAH levels were significantly higher in Beijing as compared to LA-before or LA-after (p<0.001), in association with the urinary cotinine concentrations (p<0.05). Traveling from Los Angeles to Beijing increased urinary concentrations of malondialdehyde by 51.8% (95%CI, 29.1% to 78.5%), which did not return to baseline levels, up to 4 - 10 weeks after traveling back to Los Angeles. Remarkably, while urinary 8-isoprostane concentrations were similar between Beijing and LA-before, those levels increased by 75.5% (95%CI, 48.5% to 108%) after returning to Los Angeles (LA-after), and were significantly higher than baseline (LA-before, 63.6%; 95%CI, 31.1% to 104%). Urinary concentrations of malondialdehyde and 8-isoprostane were positively associated with urinary cotinine concentrations, independently of hydroxylated-PAHs. Conclusion: Traveling from Los Angeles to Beijing increased exposures to passive smoking, which contributed to increased PAHs exposures and increased lipid peroxidation in the urine.Trial Registration: Not applicable.
What problem does this paper attempt to address?